The effect of identifying macroprolactinemia on health-care utilization and costs in patients with elevated serum prolactin levels

Value in Health

Volumn 12, Issue 6, 2009, Pages 930-934

  De Soárez, Patrícia Coelho ^a,b   De Arêa Leão Souza, Silvia Corral ^c   Vieira, José Gilberto Henriques ^c   Ferraz, Marcos Bosi ^b,c  

^a São Paulo Center for Health Economics GRIDES UNIFESP ^*  (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Fleury   (Brazil)

Author keywords

Costs and cost analysis; Health care costs; Hyperprolactinemia; Prolactin

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; GADOLINIUM; PROLACTIN;

ADULT; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION TREE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS; HYPOPHYSIS ADENOMA; IMAGING SYSTEM; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SCREENING TEST;

ADULT; BRAZIL; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DECISION TREES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; PITUITARY FUNCTION TESTS; PITUITARY GLAND; PROLACTIN;

EID: 67651219195     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00563.x     Document Type: Article

References (19)

1. Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 1974 39 : 928 35.
2. Sinha YN. Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 1995 16 : 354 69.
3. Vieira JGH. Macroprolactinemia. Arq Brasil Endocrinol Metab 2002 46 : 45 50.
4. Jackson RD, Wortsman J, Malarkey WB. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 1985 61 : 258 64.
5. Jackson RD, Wortsman J, Malarkey WB. Macroprolactinemia presenting like a pituitary tumor. Am J Med 1985 78 : 346 50.
6. Lindstedt G. Endogenous antibodies against prolactin - a "new" cause of hyperprolactinemia. Eur J Endocrinol 1994 130 : 429 32.
7. Bjoro T, Morkrid L, Wergeland R, et al. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 1995 55 : 139 47.
8. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997 34 : 252 8.
9. Vieira JG, Tachibana TT, Obara LH, Maciel RM. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1998 44 : 1758 9.
10. Hauache OM, Rocha AJ, Maia AC, Jr., et al. Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol (Oxf) 2002 57 : 327 31.
11. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 2003 49 : 1504 9.
12. Vilar L, Moura E, Canadas V, et al. Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia. Arq Bras Endocrinol Metabol 2007 51 : 86 91.
13. John R, McDowell IF, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clin Chem 2000 46 : 884 5.
14. Cavaco B, Prazeres S, Santos MA, et al. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. J Endocrinol Invest 1999 22 : 203 8.
15. Fahie-Wilson MN, McKenna TJ, Ahlquist JA, Smith TP. Macroprolactin and the Pituitary Society guidelines for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2007 67 : 638 9.
16. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 2005 90 : 3927 32.
17. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996 313 : 275 83.
18. Drummond MF, McGuire A. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford : Oxford University Press, 2001.
19. Fahie-Wilson MN. Polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1999 45 : 436 7.